All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Success: Implementing HPUS Guidelines for FDA Compliance, Part 2
Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives....
Homeopathy’s Path Ahead: 5 Ways We’re Moving the Needle Together
Homeopathy's path forward is a collective effort between manufacturers, scientists, homeopathic practitioners, and regulators. Stemming from AAHP's first Summit in 2019 with FDA keynote...
The Importance of AAHP’s 2021 Summit
Implementing HPUS Guidelines for FDA Compliance, Part 2 AAHP's newsletter editor asked me to write an article explaining the importance of the upcoming...
International Coalition of Homeopathic Associations
David Skinner of the Canadian Homeopathic Pharmaceutical Association recently wrote that there is a need for an international coalition of homeopathic associations. He makes this...
Homeopathic Pharmacopoeia Convention Activities 2020–2021
In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of...
FDA Eyes Improvements to Nonprescription Drug Labeling
What impact will that have on your products? The top line: Two years after issuing draft guidance on "innovative" nonprescription drug labeling, FDA is again...
The Environment for Homeopathy in Canada
In the global context, Canada is a very small market, but the dynamics are no different than in other large markets like the United States....
